Adu-Amankwaah J. Behind the shadows: bringing the cardiovascular secrets of long COVID into light. Eur J Prev Cardiol. 2024 Mar;5:zwae098. https://doi.org/10.1093/eurjpc/zwae098.

Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, et al. The cardiovascular aspect of COVID-19. Ann Med. 2021;53(1):227–36.

Article  CAS  PubMed  Google Scholar 

Aguida B, Chabi MM, Baouz S, Mould R, Bell JD, Pooam M, et al. Near-infrared light exposure triggers ROS to downregulate inflammatory cytokines induced by SARS-CoV-2 spike protein in human cell culture. Antioxidants (Basel). 2023;12(10):1824.

Al-Kuraishy HM, Hussien NR, Al-Niemi MS, Fahad EH, Al-Buhadily AK, Al-Gareeb AI, et al. SARS-CoV-2 induced HDL dysfunction may affect the host’s response to and recovery from COVID-19. Immun Inflamm Dis. 2023;11(5):e861.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alblaihed L, Brady WJ, Al-Salamah T, Mattu A. Dysrhythmias associated with COVID-19: review and management considerations. Am J Emerg Med. 2023;64:161–8.

Article  PubMed  Google Scholar 

AlGhatrif M, Cingolani O, Lakatta EG. The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science. JAMA Cardiol. 2020;5(7):747–8.

Article  PubMed  PubMed Central  Google Scholar 

Ali MAM, Spinler SA. COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med. 2021;31(3):143–60.

Article  CAS  PubMed  Google Scholar 

Alwani M, Yassin A, Al-Zoubi RM, Aboumarzouk OM, Nettleship J, Kelly D, et al. Sex-based differences in severity and mortality in COVID-19. Rev Med Virol. 2021;31(6):e2223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

An X, Duan L, Zhang YH, Jin D, Zhao S, Zhou RR, et al. The three syndromes and six Chinese patent medicine study during the recovery phase of COVID-19. Chin Med. 2021;16(1):44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020;323(16):1612–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arsh H, Manoj Kumar F, Simran F, Tamang S, Rehman MU, Ahmed G, et al. Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review. Ann Med Surg (Lond). 2024;86(2):899–908.

Article  PubMed  Google Scholar 

Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: possible mechanisms. Life Sci. 2020;253:117723.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrett CD, Moore HB, Yaffe MB, Moore EE. ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment. J Thromb Haemost. 2020;18(8):2060–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baytuğan NZ, Kandemir HÇ, Bezgin T. In-hospital outcomes of ST-segment elevation myocardial infarction in COVID-19 positive patients undergoing primary percutaneous intervention. Arq Bras Cardiol. 2024;121(1):e20230258.

Article  PubMed  PubMed Central  Google Scholar 

Beaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, et al. May measurement month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J. 2019;40(25):2006–17.

Article  PubMed  PubMed Central  Google Scholar 

Bechmann N, Barthel A, Schedl A, Herzig S, Varga Z, Gebhard C, et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endocrinol. 2022;10(3):221–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S, Ciccozzi M. The 2019-new coronavirus epidemic: evidence for virus evolution. J Med Virol. 2020;92(4):455–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A, et al. COVID-19 and cardiac arrhythmias. Heart Rhythm. 2020;17(9):1439–44.

Article  PubMed  PubMed Central  Google Scholar 

Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116(14):2197–206.

Article  CAS  PubMed  Google Scholar 

Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blyszczuk P. Myocarditis in humans and in experimental animal models. Front Cardiovasc Med. 2019;6:64.

Article  PubMed  PubMed Central  Google Scholar 

Bonanad C, García-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-González V, Fácila L, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–8.

Article  PubMed  PubMed Central  Google Scholar 

Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751–3.

Article  PubMed  Google Scholar 

Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, et al. Randomized trial of metformin, ivermectin, and fluvoxamine for COVID-19. N Engl J Med. 2022;387(7):599–610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis. 2023;23(10):1119–29.

Article  PubMed  Google Scholar 

Brandi ML. Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic? Rev Endocr Metab Disord. 2022;23(2):171–83.

Article  CAS  PubMed  Google Scholar 

Bugiardini R, Nava S, Caramori G, Yoon J, Badimon L, Bergami M, et al. Sex differences and disparities in cardiovascular outcomes of COVID-19. Cardiovasc Res. 2023;119(5):1190–201.

Article  CAS  PubMed  Google Scholar 

Burger AL, Kaufmann CC, Jäger B, Pogran E, Ahmed A, Wojta J, et al. Direct cardiovascular complications and indirect collateral damage during the COVID-19 pandemic: a review. Wien Klin Wochenschr. 2021;133(23–24):1289–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Butler CC, Hobbs FDR, Gbinigie OA, Rahman NM, Hayward G, Richards DB, et al. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, pl